These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38050080)

  • 1. Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC).
    Kohut K; Speight B; Young J; Way R; Wiggins J; Monje-Garcia L; Eccles DM; Foster C; Turner L; Snape K; Hanson H; ;
    J Med Genet; 2024 Jan; 61(2):142-149. PubMed ID: 38050080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT).
    Clark A; Thomas S; Hamblin A; Talley P; Kulasekararaj A; Grinfeld J; Speight B; Snape K; McVeigh TP; Snowden JA
    Br J Haematol; 2023 Apr; 201(1):35-44. PubMed ID: 36786081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group.
    Speight B; Hanson H; Turnbull C; Hardy S; Drummond J; Khorashad J; Wragg C; Page P; Parkin NW; Rio-Machin A; Fitzgibbon J; Kulasekararaj AG; Hamblin A; Talley P; McVeigh TP; Snape K;
    Br J Haematol; 2023 Apr; 201(1):25-34. PubMed ID: 36744544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice.
    Tsoulaki O; Tischkowitz M; Antoniou AC; Musgrave H; Rea G; Gandhi A; Cox K; Irvine T; Holcombe S; Eccles D; Turnbull C; Cutress R; ; Archer S; Hanson H
    Br J Cancer; 2024 Jun; 130(12):2027-2036. PubMed ID: 38834743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes:
    Hanson H; Kulkarni A; Loong L; Kavanaugh G; Torr B; Allen S; Ahmed M; Antoniou AC; Cleaver R; Dabir T; Evans DG; Golightly E; Jewell R; Kohut K; Manchanda R; Murray A; Murray J; Ong KR; Rosenthal AN; Woodward ER; Eccles DM; Turnbull C; Tischkowitz M; ; Lalloo F
    J Med Genet; 2023 May; 60(5):417-429. PubMed ID: 36411032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
    Whitworth PW; Beitsch PD; Patel R; Rosen B; Compagnoni G; Baron PL; Simmons R; Brown EA; Gold L; Holmes D; Smith LA; Kinney M; Grady I; Clark P; Barbosa K; Lyons S; Riley L; Coomer C; Curcio L; Ruiz A; Khan S; MacDonald H; Hughes K; Hardwick MK; Heald B; Munro SB; Nielsen SM; Esplin ED
    JAMA Netw Open; 2022 Sep; 5(9):e2232787. PubMed ID: 36136330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Genetic Counselor Practice and Recommendations for Pediatric Cancer Predisposition Evaluation and Surveillance.
    Zelley K; Schienda J; Gallinger B; Kohlmann WK; McGee RB; Scollon SR; Schneider KW
    Clin Cancer Res; 2024 Sep; 30(18):3983-3989. PubMed ID: 39037753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
    Hampel H; Bennett RL; Buchanan A; Pearlman R; Wiesner GL;
    Genet Med; 2015 Jan; 17(1):70-87. PubMed ID: 25394175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Predisposition Sequencing Reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer.
    Nakken S; Saveliev V; Hofmann O; Møller P; Myklebost O; Hovig E
    Int J Cancer; 2021 Dec; 149(11):1955-1960. PubMed ID: 34310709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for
    Sundar S; Manchanda R; Gourley C; George A; Wallace A; Balega J; Williams S; Wallis Y; Edmondson R; Nicum S; Frost J; Attygalle A; Fotopoulou C; Bowen R; Bell D; Gajjar K; Ramsay B; Wood NJ; Ghaem-Maghami S; Miles T; Ganesan R
    Int J Gynecol Cancer; 2021 Feb; 31(2):272-278. PubMed ID: 33468564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.
    Bedrosian I; Somerfield MR; Achatz MI; Boughey JC; Curigliano G; Friedman S; Kohlmann WK; Kurian AW; Laronga C; Lynce F; Norquist BS; Plichta JK; Rodriguez P; Shah PD; Tischkowitz M; Wood M; Yadav S; Yao K; Robson ME
    J Clin Oncol; 2024 Feb; 42(5):584-604. PubMed ID: 38175972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.
    McVeigh TP; Sweeney KJ; Brennan DJ; McVeigh UM; Ward S; Strydom A; Seal S; Astbury K; Donnellan P; Higgins J; Keane M; Kerin MJ; Malone C; McGough P; McLaughlin R; O'Leary M; Rushe M; Barry MK; MacGregor G; Sugrue M; Yousif A; Al-Azawi D; Berkeley E; Boyle TJ; Connolly EM; Nolan C; Richardson E; Giffney C; Doyle SB; Broderick S; Boyd W; McVey R; Walsh T; Farrell M; Gallagher DJ; Rahman N; George AJ
    Fam Cancer; 2023 Apr; 22(2):135-149. PubMed ID: 36029389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report from the UK and Eire Association of Genetic Nurses and Counsellors (AGNC) supervision working group on genetic counselling supervision.
    Clarke A; Middleton A; Cowley L; Guilbert P; Macleod R; Clarke A; Tran V;
    J Genet Couns; 2007 Apr; 16(2):127-42. PubMed ID: 17308871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
    Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
    Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-syndrome, multi-gene risk modeling for individuals with a family history of cancer with the novel R package PanelPRO.
    Lee G; Liang JW; Zhang Q; Huang T; Choirat C; Parmigiani G; Braun D
    Elife; 2021 Aug; 10():. PubMed ID: 34406119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group.
    Bakhuizen JJ; Hanson H; van der Tuin K; Lalloo F; Tischkowitz M; Wadt K; Jongmans MCJ; ; ;
    Fam Cancer; 2021 Oct; 20(4):337-348. PubMed ID: 34170462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.
    Geller G; Botkin JR; Green MJ; Press N; Biesecker BB; Wilfond B; Grana G; Daly MB; Schneider K; Kahn MJ
    JAMA; 1997 May; 277(18):1467-74. PubMed ID: 9145720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group.
    Taylor A; Brady AF; Frayling IM; Hanson H; Tischkowitz M; Turnbull C; Side L;
    J Med Genet; 2018 Jun; 55(6):372-377. PubMed ID: 29661970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network.
    Garrett A; Callaway A; Durkie M; Cubuk C; Alikian M; Burghel GJ; Robinson R; Izatt L; Talukdar S; Side L; Cranston T; Palmer-Smith S; Baralle D; Berry IR; Drummond J; Wallace AJ; Norbury G; Eccles DM; Ellard S; Lalloo F; Evans DG; Woodward E; Tischkowitz M; Hanson H; Turnbull C;
    J Med Genet; 2020 Dec; 57(12):829-834. PubMed ID: 32170000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.